Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Weatherall

Showing results (341-350 of 363) with videos related to

Pageof 37
Sort By:
ERJ Open Research|September 27, 2023
The Anti-Inflammatory Reliever (AIR) Algorithm Study: a protocol for a single-group study of an AIR stepwise approach to the treatment of adult asthmaPepa Bruce, Lee Hatter, Claire Houghton, et al.
The European Respiratory Journal|October 16, 2020
Budesonide-formoterol reliever therapy in intermittent <i>versus</i> mild persistent asthmaAlberto Papi, Irene Braithwaite, Stefan Ebmeier, et al.
The New England Journal of Medicine|October 6, 2015
Acetaminophen for Fever in Critically Ill Patients with Suspected InfectionPaul Young, Manoj Saxena, Rinaldo Bellomo, et al.
Vaccine: X|December 20, 2022
COVID-19 vaccination and the skin to deltoid MUSCLE distance in adults with diabetesMarjan Doppen, Ali Mirjalili, Matire Harwood, et al.
ERJ Open Research|January 21, 2026
Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trialWilliam Leung, Helen K Reddel, Tiffany Hung, et al.
Headache|May 20, 2022
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysisMessoud Ashina, Stewart J Tepper, Jan Lewis Brandes, et al.
Frontiers in Nutrition|December 27, 2023
He Rourou Whai Painga, an Aotearoa New Zealand dietary pattern for metabolic health and whānau wellbeing: protocol for a randomized controlled trialFiona E Lithander, Amber Parry Strong, Andrea Braakhuis, et al.
Diabetes, Obesity & Metabolism|October 29, 2024
A Mediterranean dietary pattern intervention does not improve cardiometabolic risk but does improve quality of life and body composition in an Aotearoa New Zealand population at increased cardiometabolic risk: A randomised controlled trialJeremy D Krebs, Amber Parry-Strong, Andrea Braakhuis, et al.
The Lancet. Respiratory Medicine|January 11, 2026
Budesonide-formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trialJonathan H Noble, Orlagh Bean, Melissa Perry, et al.
Eclinicalmedicine|December 8, 2025
An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trialPepa Bruce, Claire Houghton, Lee Hatter, et al.
Pageof 37

Showing results (341-350 of 363) with videos related to

Sort By:
Pageof 37
ERJ Open Research|September 27, 2023
The Anti-Inflammatory Reliever (AIR) Algorithm Study: a protocol for a single-group study of an AIR stepwise approach to the treatment of adult asthmaPepa Bruce, Lee Hatter, Claire Houghton, et al.
The European Respiratory Journal|October 16, 2020
Budesonide-formoterol reliever therapy in intermittent <i>versus</i> mild persistent asthmaAlberto Papi, Irene Braithwaite, Stefan Ebmeier, et al.
The New England Journal of Medicine|October 6, 2015
Acetaminophen for Fever in Critically Ill Patients with Suspected InfectionPaul Young, Manoj Saxena, Rinaldo Bellomo, et al.
Vaccine: X|December 20, 2022
COVID-19 vaccination and the skin to deltoid MUSCLE distance in adults with diabetesMarjan Doppen, Ali Mirjalili, Matire Harwood, et al.
ERJ Open Research|January 21, 2026
Cost-effectiveness of as-needed budesonide-formoterol in adults with mild asthma: the Novel START trialWilliam Leung, Helen K Reddel, Tiffany Hung, et al.
Headache|May 20, 2022
Long-term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysisMessoud Ashina, Stewart J Tepper, Jan Lewis Brandes, et al.
Frontiers in Nutrition|December 27, 2023
He Rourou Whai Painga, an Aotearoa New Zealand dietary pattern for metabolic health and whānau wellbeing: protocol for a randomized controlled trialFiona E Lithander, Amber Parry Strong, Andrea Braakhuis, et al.
Diabetes, Obesity & Metabolism|October 29, 2024
A Mediterranean dietary pattern intervention does not improve cardiometabolic risk but does improve quality of life and body composition in an Aotearoa New Zealand population at increased cardiometabolic risk: A randomised controlled trialJeremy D Krebs, Amber Parry-Strong, Andrea Braakhuis, et al.
The Lancet. Respiratory Medicine|January 11, 2026
Budesonide-formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trialJonathan H Noble, Orlagh Bean, Melissa Perry, et al.
Eclinicalmedicine|December 8, 2025
An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trialPepa Bruce, Claire Houghton, Lee Hatter, et al.
Pageof 37